 |
|
|
| |
Open-Label Phase 1 Study to Characterize the Effects of a Strong CYP3A4 Inducer on the Pharmacokinetics of MK-8527, a Nucleoside Reverse Transcriptase Translocation Inhibitor, in Adults Without HIV
|
| |
| |
IAS Brazil 2026
Russ P. Carstens1*; Yash Kapoor1; Arinjita Bhattacharyya1; Bhavna Kantesaria1; Graigory C. Garrett1; Ryan Vargo1; Megan Van Scoyoc2; Jing Jin2; Michelle Valentine2; Jesse C. Nussbaum1
1Merck & Co., Inc., Rahway, NJ, USA; 2Celerion, Lincoln, NE, USA
*Presenting author
|
| |
|
|
|
|
|
